Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack—blocking the energy supply T cells depend on. The study, published Oct. 23 in Nature, points toward a promising new immunotherapy approach for ovarian cancer, which is notoriously aggressive and hard to treat.
Eli Lilly and Boehringer Ingelheim pay tribute to hip-hop anniversary in chronic kidney disease campaign with Rob Base
“It takes two” to make diagnoses of chronic kidney disease go right, Eli Lilly and Boehringer Ingelheim suggest in their latest campaign featuring hip-hop artist
November 2, 2023